Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | +2.30% | +8.54% | +74.51% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.51% | 12.37M | |
+9.88% | 118B | |
+10.04% | 106B | |
-11.11% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.69% | 15.97B | |
+6.80% | 14.03B | |
+17.87% | 11.67B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics Hires Dr. David Weiner as Interim Chief Medical Officer